A detailed history of Federated Hermes, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 716,779 shares of VNDA stock, worth $3.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
716,779
Previous 715,645 0.16%
Holding current value
$3.46 Million
Previous $4.04 Million 16.87%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.61 - $6.34 $5,227 - $7,189
1,134 Added 0.16%
716,779 $3.36 Million
Q2 2024

Aug 08, 2024

SELL
$3.91 - $6.5 $97 - $162
-25 Reduced -0.0%
715,645 $4.04 Million
Q1 2024

May 14, 2024

SELL
$3.47 - $4.61 $355,178 - $471,865
-102,357 Reduced 12.51%
715,670 $2.94 Million
Q4 2023

Jan 31, 2024

SELL
$3.38 - $4.58 $282,169 - $382,347
-83,482 Reduced 9.26%
818,027 $3.45 Million
Q3 2023

Nov 13, 2023

SELL
$4.28 - $6.57 $568,465 - $872,620
-132,819 Reduced 12.84%
901,509 $3.89 Million
Q2 2023

Aug 14, 2023

SELL
$5.9 - $6.95 $61,649 - $72,620
-10,449 Reduced 1.0%
1,034,328 $6.82 Million
Q1 2023

May 08, 2023

BUY
$6.18 - $7.99 $1.49 Million - $1.92 Million
240,859 Added 29.96%
1,044,777 $7.09 Million
Q4 2022

Feb 13, 2023

BUY
$6.87 - $10.96 $2.13 Million - $3.4 Million
310,073 Added 62.79%
803,918 $5.94 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $80,844 - $100,712
8,564 Added 1.76%
493,845 $4.88 Million
Q2 2022

Aug 15, 2022

SELL
$9.31 - $11.84 $495,859 - $630,610
-53,261 Reduced 9.89%
485,281 $5.29 Million
Q1 2022

May 13, 2022

SELL
$10.84 - $16.55 $44,682 - $68,219
-4,122 Reduced 0.76%
538,542 $6.09 Million
Q4 2021

Feb 14, 2022

SELL
$15.69 - $21.14 $82,027 - $110,519
-5,228 Reduced 0.95%
542,664 $8.51 Million
Q3 2021

Nov 15, 2021

BUY
$15.35 - $21.27 $540,703 - $749,235
35,225 Added 6.87%
547,892 $9.39 Million
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $110,535 - $151,344
7,036 Added 1.39%
512,667 $11 Million
Q1 2021

May 13, 2021

BUY
$13.42 - $20.28 $551,642 - $833,629
41,106 Added 8.85%
505,631 $7.6 Million
Q4 2020

Feb 12, 2021

BUY
$9.77 - $13.81 $24,571 - $34,732
2,515 Added 0.54%
464,525 $6.1 Million
Q3 2020

Nov 12, 2020

BUY
$9.32 - $12.02 $1.9 Million - $2.45 Million
203,873 Added 78.98%
462,010 $4.46 Million
Q2 2020

Aug 13, 2020

BUY
$9.66 - $12.02 $145,547 - $181,105
15,067 Added 6.2%
258,137 $2.95 Million
Q1 2020

May 13, 2020

BUY
$7.5 - $16.8 $1.04 Million - $2.33 Million
138,973 Added 133.5%
243,070 $2.52 Million
Q4 2019

Feb 14, 2020

SELL
$12.38 - $17.47 $4.49 Million - $6.34 Million
-362,810 Reduced 77.7%
104,097 $1.71 Million
Q3 2019

Nov 14, 2019

BUY
$12.27 - $15.79 $2.87 Million - $3.69 Million
233,680 Added 100.19%
466,907 $6.2 Million
Q2 2019

Aug 14, 2019

SELL
$13.37 - $18.85 $292,361 - $412,192
-21,867 Reduced 8.57%
233,227 $3.29 Million
Q1 2019

May 10, 2019

BUY
$17.59 - $31.05 $2.13 Million - $3.76 Million
121,038 Added 90.29%
255,094 $4.69 Million
Q4 2018

Feb 13, 2019

BUY
$18.97 - $31.47 $2.53 Million - $4.19 Million
133,264 Added 16826.26%
134,056 $3.5 Million
Q3 2018

Nov 13, 2018

SELL
$18.25 - $23.0 $444,186 - $559,797
-24,339 Reduced 96.85%
792 $19,000
Q3 2017

Nov 13, 2017

BUY
$15.4 - $18.85 $387,017 - $473,719
25,131
25,131 $450,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $273M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.